Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.77

0.02 (1.99%)

At close: May 02, 2025, 2:47 PM

Xilio Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-58.24M	-76.4M	-88.22M	-75.8M	-55.22M	-17.31M
Depreciation & Amortization	1.64M	1.9M	1.85M	1.5M	1.06M	240K
Stock-Based Compensation	6.43M	7.38M	8.42M	4.96M	1.3M	112K
Other Working Capital	30.26M	2.47M	1.52M	-8.98M	13.68M	-173K
Other Non-Cash Items	3K	-3.97M	224K	173K	39K	56K
Deferred Income Tax	n/a	2.06M	n/a	222K	126K	-1.74M
Change in Working Capital	31.78M	405K	2M	-11.8M	16.6M	797K
Operating Cash Flow	-18.38M	-68.62M	-75.72M	-80.75M	-36.09M	-17.84M
Capital Expenditures	-36K	-486K	-1.87M	-1.1M	-2.19M	-715K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-36K	-486K	-1.87M	-1.1M	-2.19M	-715K
Debt Repayment	-3.38M	-6.75M	-85K	-110K	-99K	9.95M
Common Stock Repurchased	n/a	194K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	25.75M	202K	16K	-467K	159K	-9.95M
Financial Cash Flow	29.2M	-6.55M	-69K	260.67M	10.03M	60.02M
Net Cash Flow	10.78M	-75.66M	-77.66M	178.82M	-28.25M	41.46M
Free Cash Flow	-18.41M	-69.11K	-77.59M	-81.85M	-38.28M	-18.56M